J J Ong1, K Fethers2, B P Howden3, C K Fairley4, E P F Chow4, D A Williamson3, I Petalotis3, E Aung2, K Kanhutu5, V De Petra3, M Y Chen6. 1. Melbourne Sexual Health Centre, Alfred Health, Melbourne, Vic., Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic., Australia. Electronic address: Jong@mshc.org.au. 2. Melbourne Sexual Health Centre, Alfred Health, Melbourne, Vic., Australia. 3. Microbiological Diagnostic Unit, Department of Microbiology and Immunology at the Peter Doherty Institution for Infection and Immunity, University of Melbourne, Melbourne, Vic., Australia. 4. Melbourne Sexual Health Centre, Alfred Health, Melbourne, Vic., Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic., Australia. 5. University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Vic., Australia. 6. Melbourne Sexual Health Centre, Alfred Health, Melbourne, Vic., Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic., Australia. Electronic address: MChen@mshc.org.au.
Abstract
OBJECTIVES: Guidelines regarding whether men who have sex with men (MSM) without symptoms of urethritis should be screened for urethral gonorrhoea differ between countries. We examined the rate of asymptomatic urethral gonorrhoea in MSM using sensitive nucleic acid amplification testing. METHODS: This study was conducted on consecutive MSM attending the Melbourne Sexual Health Centre between July 2015 and May 2016 for sexually transmitted infections screening. Gonorrhoea testing with the Aptima Combo 2 (AC2) assay was performed on all urine specimens obtained from MSM, whether symptoms of urethritis were present or not. Men were classified as having: typical discharge if they reported symptoms suggesting purulent discharge; other symptoms if they reported other symptoms of urethritis; and no symptoms if they reported no urethral symptoms. RESULTS: During the study period, there were 7941 clinic visits by 5947 individual MSM with 7090 urine specimens obtained from 5497 individual MSM tested with the AC2 assay. Urethral gonorrhoea was detected in 242 urine specimens from 228 individual MSM. The majority (189/242, 78%, 95% CI 73-83) reported typical discharge, 27/242 (11%, 95% CI 8-16) reported other urethral symptoms, and 26/242 (11%, 95% CI 7-15) reported no symptoms on the day of presentation and testing. Among men with urethral gonorrhoea, the proportions with concurrent pharyngeal or rectal gonorrhoea were 32% (134/210) and 64% (74/235), respectively. The mean interval between last reported sexual contact and onset of typical urethral discharge, where present, was 3.9 days. CONCLUSION: The findings from our study lend support to guidelines that recommend screening asymptomatic MSM for urethral gonorrhoea.
OBJECTIVES: Guidelines regarding whether men who have sex with men (MSM) without symptoms of urethritis should be screened for urethral gonorrhoea differ between countries. We examined the rate of asymptomatic urethral gonorrhoea in MSM using sensitive nucleic acid amplification testing. METHODS: This study was conducted on consecutive MSM attending the Melbourne Sexual Health Centre between July 2015 and May 2016 for sexually transmitted infections screening. Gonorrhoea testing with the Aptima Combo 2 (AC2) assay was performed on all urine specimens obtained from MSM, whether symptoms of urethritis were present or not. Men were classified as having: typical discharge if they reported symptoms suggesting purulent discharge; other symptoms if they reported other symptoms of urethritis; and no symptoms if they reported no urethral symptoms. RESULTS: During the study period, there were 7941 clinic visits by 5947 individual MSM with 7090 urine specimens obtained from 5497 individual MSM tested with the AC2 assay. Urethral gonorrhoea was detected in 242 urine specimens from 228 individual MSM. The majority (189/242, 78%, 95% CI 73-83) reported typical discharge, 27/242 (11%, 95% CI 8-16) reported other urethral symptoms, and 26/242 (11%, 95% CI 7-15) reported no symptoms on the day of presentation and testing. Among men with urethral gonorrhoea, the proportions with concurrent pharyngeal or rectal gonorrhoea were 32% (134/210) and 64% (74/235), respectively. The mean interval between last reported sexual contact and onset of typical urethral discharge, where present, was 3.9 days. CONCLUSION: The findings from our study lend support to guidelines that recommend screening asymptomatic MSM for urethral gonorrhoea.
Authors: Evelyn E Nash; Cau D Pham; Brian Raphael; Emily R Learner; Kerry Mauk; Josh Weiner; Christie Mettenbrink; Christina S Thibault; Acasia Fukuda; Oana Dobre-Buonya; Jamie M Black; Kimberly Johnson; Kevin Sellers; Karen Schlanger Journal: Sex Transm Dis Date: 2021-12-01 Impact factor: 3.868
Authors: Anna Berzkalns; Christina S Thibault; Lindley A Barbee; Matthew R Golden; Christine Khosropour; Roxanne P Kerani Journal: Sex Transm Dis Date: 2021-08-01 Impact factor: 2.830
Authors: Eric P F Chow; Sandra Walker; Jane S Hocking; Catriona S Bradshaw; Marcus Y Chen; Sepehr N Tabrizi; Benjamin P Howden; Matthew G Law; Kate Maddaford; Tim R H Read; David A Lewis; David M Whiley; Lei Zhang; Andrew E Grulich; John M Kaldor; Vincent J Cornelisse; Samuel Phillips; Basil Donovan; Anna M McNulty; David J Templeton; Norman Roth; Richard Moore; Christopher K Fairley Journal: BMC Infect Dis Date: 2017-06-28 Impact factor: 3.090
Authors: Vincent J Cornelisse; Catriona S Bradshaw; Eric P F Chow; Deborah A Williamson; Christopher K Fairley Journal: Emerg Infect Dis Date: 2019-07 Impact factor: 6.883
Authors: Mario Martín-Sánchez; Richard Case; Christopher Fairley; Jane S Hocking; Catriona Bradshaw; Jason Ong; Marcus Y Chen; Eric P F Chow Journal: BMJ Open Date: 2020-11-24 Impact factor: 2.692
Authors: Vincent J Cornelisse; Lei Zhang; Matthew Law; Marcus Y Chen; Catriona S Bradshaw; Clare Bellhouse; Christopher K Fairley; Eric P F Chow Journal: BMC Infect Dis Date: 2018-02-27 Impact factor: 3.090
Authors: Kristian Alfsnes; Vegard Eldholm; Anne Olaug Olsen; Ola Brønstad Brynildsrud; Jon Bohlin; Martin Steinbakk; Dominique A Caugant Journal: Microb Genom Date: 2020-03-19